$32.80

-0.19 (-0.58%)
Live
Previous Close

$32.8

Day Range

$31.91 - $32.83

Previous Day Range

$32.315 - $33.86

Market Cap

$2.2 billion USD

Day Vol.

416123

Previous Day Vol.

429272

Currency

USD

Primary Exchange

Nasdaq

Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling scienc...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Galapagos NV announced the appointment of Aaron Cox as their new Chief Financial Officer, effective July 7, 2025. Cox brings over two decades of leadership experience in the biotechnology and capital markets sectors, having previously served as Executive Vice President and CFO at Horizon Therapeutics.

Related tickers: GLPG.

Read Full Article

Galapagos has appointed Aaron Cox, former CFO of Horizon Therapeutics, as its new Chief Financial Officer. Cox brings extensive experience in biotechnology, capital markets, and mergers and acquisitions. He will play a key role in accelerating Galapagos' pipeline growth and value creation.

Related tickers: GLPG, AMGN.

Read Full Article
Trending Tickers

Please sign in to view